Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor, decreases serum uric acid levels in type 2 diabetic patients partly by suppressing xanthine oxidase activity

Published 2014 View Full Article

Authors

Keywords

Journal

INTERNATIONAL JOURNAL OF CARDIOLOGY

Volume 176, Issue 2, Pages 550-552

Publisher

Elsevier BV

Online

2014-07-12

DOI

10.1016/j.ijcard.2014.07.023

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

INTERNATIONAL JOURNAL OF CARDIOLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Ask a Question. Answer a Question.